The molybdenum shortage has mostly abated which is great for our patients. I was interviewed on BBC radio Northern Ireland about it as they were interested about the implications of a nuclear reactor fault and was this another Chernobyl! I was able to reassure the people of Northern Ireland and explain the importance of nuclear medicine.

The molecular radiotherapy consortium continues to develop and the BNMS is a key stakeholder in this. We are well represented by Glen Flux and Sabina Disdarevic on its steering committee. We hope that NICE will approve Lu177 PSMA in January and that then we can treat our patients on the NHS.  Once approved we will need to build staffing and infrastructure to deliver this new service. Industry partners will be keen to support this, I think.

NHS England has started to work on the service specification for the next round of PET-CT commissioning. The BNMS is stakeholder in this and I will keep you posted as this develops. I would like to congratulate Wai-Lup Wong who has been appointed as the National Speciality Advisor for Nuclear Medicine at NHS England.  This extends his previous PET-CT role to encompass all of diagnostic and therapeutic nuclear medicine.

Abstract submission is opening for our BNMS Spring meeting so I would encourage you to submit and attend the meeting which I am sure will be a great success given the form of our recent meetings.

I wish you all a merry Christmas and a Happy New Year! I hope you all get a well-earned break and have some time to recharge before the onslaught of ever-increasing demand we will all experience next year.

Prof Richard Graham

BNMS President